We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+10.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
+$3.77M
Cap. Flow
-$171K
Cap. Flow %
-0.17%
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
36
Closed
61

Top Buys

Rank Stock Value
1
NVAX icon
Novavax
NVAX
+$1.85M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$1.67M
3
TSVT
2seventy bio
TSVT
+$1.59M
4
ARQT icon
Arcutis Biotherapeutics
ARQT
+$1.37M
5
ADCT icon
ADC Therapeutics
ADCT
+$1.19M

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$12.8M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$2.1M
3
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$2.08M
4
WBA
Walgreens Boots Alliance
WBA
+$1.6M
5
SNY icon
Sanofi
SNY
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 56.8%
2 Real Estate 15.08%
3 Financials 8.32%
4 Energy 6.75%
5 Industrials 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAY icon
51
Accuray
ARAY
$30.8M
$732K 0.72%
350,000
– –
GILD icon
52
Gilead Sciences
GILD
$167B
$730K 0.72%
8,500
-5,000
-37% -$396K
WELL icon
53
Welltower
WELL
$172B
$725K 0.72%
11,059
– –
MTG icon
54
MGIC Investment
MTG
$6.23B
$701K 0.69%
53,900
– –
KNSA icon
55
Kiniksa Pharmaceuticals
KNSA
$4.92B
$674K 0.67%
45,000
+2,000
+5% +$29.1K
CLDX icon
56
Celldex Therapeutics
CLDX
$2.77B
$669K 0.66%
15,000
-2,000
-12% -$71.4K
MOR
57
DELISTED
MorphoSys AG American Depositary Shares
MOR
$662K 0.65%
185,000
– –
AVAH icon
58
Aveanna Healthcare
AVAH
$2.11B
$657K 0.65%
842,000
+242,000
+40% +$253K
MRTX
59
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$634K 0.63%
+14,000
New +$906K
UTHR icon
60
United Therapeutics
UTHR
$22.7B
$626K 0.62%
2,250
– –
NUVB icon
61
Nuvation Bio
NUVB
$2.02B
$624K 0.62%
325,000
+110,000
+51% +$223K
ACT icon
62
Enact Holdings
ACT
$6.49B
$612K 0.6%
25,367
-15,145
-37% -$370K
AMRN
63
Amarin Corp
AMRN
$292M
$605K 0.6%
25,000
– –
AMYT
64
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$591K 0.58%
81,000
+25,000
+45% +$176K
MPC icon
65
Marathon Petroleum
MPC
$91.3B
$561K 0.55%
4,819
+2,532
+111% +$289K
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$15.5B
$558K 0.55%
3,500
– –
VUZI icon
67
Vuzix
VUZI
$188M
$546K 0.54%
150,000
– –
APA icon
68
APA Corp
APA
$12.4B
$540K 0.53%
11,571
+6,260
+118% +$280K
EXEL icon
69
Exelixis
EXEL
$14.1B
$529K 0.52%
+33,000
New +$538K
VLO icon
70
Valero Energy
VLO
$91.9B
$514K 0.51%
4,055
+2,301
+131% +$289K
COP icon
71
ConocoPhillips
COP
$140B
$505K 0.5%
4,282
+2,913
+213% +$354K
XOM icon
72
ExxonMobil
XOM
$611B
$487K 0.48%
4,419
+3,005
+213% +$322K
KSCP icon
73
Knightscope
KSCP
$25.4M
$473K 0.47%
5,000
+1,400
+39% +$167K
NUVL
74
DELISTED
Nuvalent
NUVL
$462K 0.46%
+15,500
New +$432K
WBA
75
DELISTED
Walgreens Boots Alliance
WBA
$448K 0.44%
12,000
-42,500
-78% -$1.6M
1 2
3
4 5

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, AlphaCentric Advisors held 226 positions worth $101M, up 3.9% from $97.4M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors's Q4 2022 filing shows 42 new, 62 increased, 36 reduced and 61 closed positions. Its largest new stake was Novavax: 105,000 shares worth $1.08M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 44% a quarter earlier, followed by Real Estate and Financials.

  • AlphaCentric Advisors's largest Q4 2022 buy was Novavax: 105,000 shares worth $1.08M.
  • AlphaCentric Advisors added most to 2seventy bio in Q4 2022, an estimated $1.59M increase.
  • AlphaCentric Advisors's biggest Q4 2022 reduction was Walgreens Boots Alliance, cutting an estimated $1.6M.
  • AlphaCentric Advisors fully exited iShares 1-3 Year Treasury Bond ETF in Q4 2022, selling an estimated $12.8M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $101M portfolio in Q4 2022.
  • AlphaCentric Advisors opened 42 new positions and closed 61 in Q4 2022.
  • AlphaCentric Advisors's portfolio value rose 3.9% quarter-over-quarter to $101M.

Based on AlphaCentric Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.